Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Withdrawn × ADI PEG20 × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Completed 6 Terminated 3 Active not recruiting 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 30 Radiotherapy 21 Cisplatin 21 fludarabine 19 Paclitaxel 19 Nivolumab 17 Magnetic Resonance Spectroscopy 16 Carboplatin 16 pembrolizumab 15 fludarabine phosphate 14 Specimen Handling 14 Gemcitabine 14 Biopsy 12 Radiation 11 Docetaxel 10 Cytarabine 10 Radiosurgery 9 Melphalan 9 Filgrastim 9 Etoposide 9 Doxorubicin 9 Dexamethasone 9 Ipilimumab 8 Granulocyte Colony-Stimulating Factor 8 venetoclax 7 trametinib 7 ibrutinib 7 durvalumab 7 Sorafenib 7 Rituximab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03498222 2020-02-25

iTRAP

Queen Mary University of London

Phase 1 Withdrawn

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡